Omega Fund Management, LLC

Q1 2025 13F Holdings

  • Location
    boston, MA
  • Num holdings

    13

  • Value ($000)

    $169,462

  • Date Filed
    05/15/2025
  • Form type
    13F-HR
  • CIK
    0001637359
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

Kestra Med Technologies Ltd.

COMMON STOCK
G52441105
$44.75M
26 %

1,795,893

---

Bicara Therapeutics Inc.

COMMON STOCK
055477103
$28.73M
17 %

2,204,650

---

Beta Bionics Inc.

COMMON STOCK
08659B102
$24.34M
14 %

1,988,287

NUVB
NUVB

Nuvation Bio

COMMON STOCK CLASS A
67080N101
$23.01M
14 %

13,072,340

REPL
REPL

Replimune Group

COMMON STOCK
76029N106
$19.26M
11 %

1,975,203

---

Upstream Bio Inc.

COMMON STOCK
91678A107
$12.46M
7 %

2,036,293

LXEO
LXEO

Lexeo Therapeutics

COMMON STOCK
52886X107
$4.11M
2 %

1,184,636

ALMS
ALMS

Alumis Inc.

COMMON STOCK
022307102
$4.01M
2 %

653,223

IKNA
IKNA

Ikena Oncology

COMMON STOCK
45175G108
$2.88M
2 %

2,249,123

ENGN
ENGN

enGene Holdings Inc.

COMMON STOCK
29286M105
$2.36M
1 %

526,357

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 13